Photocure (PHO) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.054x

Based on the latest financial reports, Photocure (PHO) has a cash flow conversion efficiency ratio of 0.054x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Nkr26.43 Million ≈ $2.78 Million USD) by net assets (Nkr486.60 Million ≈ $51.20 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See PHO defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Photocure - Cash Flow Conversion Efficiency Trend (2002–2024)

This chart illustrates how Photocure's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Photocure Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Photocure ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Surgical Science Sweden AB
ST:SUS
0.017x
Mainstreet Bank
NASDAQ:MNSB
0.031x
QINGCI GAMES INC. -00001
F:Z56
N/A
Black Spade Acquisition III Co
NYSE:BIII
-0.002x
Flutter Entertainment PLC
LSE:FLTR
0.034x
Atlan Holdings Bhd
KLSE:7048
0.149x
Dynamic Cables Limited
NSE:DYCL
0.011x
Bjorn Borg AB
ST:BORG
0.364x

Annual Cash Flow Conversion Efficiency for Photocure (2002–2024)

The table below shows the annual cash flow conversion efficiency of Photocure from 2002 to 2024. For the full company profile with market capitalisation and key ratios, see Photocure market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 Nkr501.72 Million
≈ $52.79 Million
Nkr76.75 Million
≈ $8.08 Million
0.153x +151.36%
2023-12-31 Nkr482.85 Million
≈ $50.81 Million
Nkr29.39 Million
≈ $3.09 Million
0.061x +1495.53%
2022-12-31 Nkr462.73 Million
≈ $48.69 Million
Nkr-2.02 Million
≈ $-212.35K
-0.004x -109.18%
2021-12-31 Nkr502.63 Million
≈ $52.89 Million
Nkr23.89 Million
≈ $2.51 Million
0.048x +54.94%
2020-12-31 Nkr508.13 Million
≈ $53.47 Million
Nkr15.59 Million
≈ $1.64 Million
0.031x -69.03%
2019-12-31 Nkr208.59 Million
≈ $21.95 Million
Nkr20.66 Million
≈ $2.17 Million
0.099x +172.38%
2018-12-31 Nkr176.34 Million
≈ $18.56 Million
Nkr-24.12 Million
≈ $-2.54 Million
-0.137x -26.45%
2017-12-31 Nkr218.08 Million
≈ $22.95 Million
Nkr-23.59 Million
≈ $-2.48 Million
-0.108x -242.01%
2016-12-31 Nkr251.94 Million
≈ $26.51 Million
Nkr19.19 Million
≈ $2.02 Million
0.076x +176.09%
2015-12-31 Nkr210.06 Million
≈ $22.10 Million
Nkr-21.03 Million
≈ $-2.21 Million
-0.100x -294.80%
2014-12-31 Nkr240.06 Million
≈ $25.26 Million
Nkr-6.09 Million
≈ $-640.63K
-0.025x +93.16%
2013-12-31 Nkr269.12 Million
≈ $28.32 Million
Nkr-99.72 Million
≈ $-10.49 Million
-0.371x -156.53%
2012-12-31 Nkr380.27 Million
≈ $40.02 Million
Nkr-54.93 Million
≈ $-5.78 Million
-0.144x -84.12%
2011-12-31 Nkr439.34 Million
≈ $46.23 Million
Nkr-34.47 Million
≈ $-3.63 Million
-0.078x -330.80%
2010-12-31 Nkr458.85 Million
≈ $48.28 Million
Nkr15.60 Million
≈ $1.64 Million
0.034x -95.55%
2009-12-31 Nkr415.78 Million
≈ $43.75 Million
Nkr317.44 Million
≈ $33.40 Million
0.763x +355.48%
2008-12-31 Nkr199.69 Million
≈ $21.01 Million
Nkr-59.68 Million
≈ $-6.28 Million
-0.299x +18.77%
2007-12-31 Nkr259.99 Million
≈ $27.36 Million
Nkr-95.66 Million
≈ $-10.07 Million
-0.368x -281.35%
2006-12-31 Nkr326.94 Million
≈ $34.40 Million
Nkr66.33 Million
≈ $6.98 Million
0.203x +113.94%
2005-12-31 Nkr48.47 Million
≈ $5.10 Million
Nkr-70.54 Million
≈ $-7.42 Million
-1.455x -147.85%
2004-12-31 Nkr85.57 Million
≈ $9.00 Million
Nkr-50.25 Million
≈ $-5.29 Million
-0.587x -9.86%
2003-12-31 Nkr131.90 Million
≈ $13.88 Million
Nkr-70.51 Million
≈ $-7.42 Million
-0.535x -75.36%
2002-12-31 Nkr167.00 Million
≈ $17.57 Million
Nkr-50.91 Million
≈ $-5.36 Million
-0.305x --

About Photocure

OL:PHO Norway Drug Manufacturers - Specialty & Generic
Market Cap
$171.35 Million
Nkr1.63 Billion NOK
Market Cap Rank
#17273 Global
#142 in Norway
Share Price
Nkr61.20
Change (1 day)
+3.73%
52-Week Range
Nkr50.30 - Nkr79.00
All Time High
Nkr150.90
About

Photocure ASA, together with its subsidiaries, engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products. It operates through Commercial Franchise and Development Portfolio segments. The company offers Hexvix/Cysview for the detection and management of bladder cancer. It also develops Cevira for the treatment of human papilloma virus-induced ce… Read more